November 25, 2021
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer
Media
November 24, 2021
Oncopeptides publishes Q3 2021 report
November 19, 2021
Invitation to presentation of the Q3 2021 results
November 18, 2021
Nordic Nanovector ASA: Results for the Third Quarter 2021
November 15, 2021
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
November 15, 2021
Spruce Biosciences Appoints Mike Grey as Interim CEO
November 15, 2021
Jakob Lindberg appointed CEO of Oncopeptides
November 12, 2021
Carisma Therapeutics Presents Data from Phase I Clinical Trial of CT-0508, A HER2 Targeted CAR-Macrophage
November 10, 2021
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
November 09, 2021
Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma
